Skip to main content
. 2012 Sep 28;12(2):387–394. doi: 10.1102/1470-7330.2012.9038

Table 1.

Overview of clinical (MR- or ultrasound-guided) HIFU liver tumour ablation studies

Authors[Ref.] Year Patients (n) Image guidance Study design Study objective
Okada et al.[38] 2006 1 MR-guided Case report Feasibility
Visioli et al.[33] 1999 6 Ultrasound-guided Prospective phase I patient series Safety and feasibility
Wu et al.[36] 2004 474 Ultrasound-guided Retrospective patient series Safety and feasibility
Illing et al.[34] 2005 22 Ultrasound-guided Prospective patient series Safety and efficacy
Li et al.[54] 2007 151 Ultrasound-guided Case-control study Tumour response and survival
Orsi et al.[52] 2010 23 Ultrasound-guided Prospective patient series Safety and efficacy
Jung et al.[55] 2011 79 Ultrasound-guided Retrospective patient series Complications
Xu et al.[56] 2011 145 Ultrasound-guided Prospective patient series Efficacy and complications
Zhang et al.[57] 2011 27 Ultrasound-guided Prospective patient series Imaging response
Jin et al.[58] 2011 73 Ultrasound-guided Prospective patient series Long-term follow-up
Fukuda et al.[59] 2011 12 Ultrasound-guided Prospective patient series Safety and efficacy